Based on network pharmacology, molecular docking and experimental verification to reveal the mechanism of Andrographis paniculata against solar dermatitis

• Published in: Phytomedicine (Stuttgart) Vol. 135; p. 156025
• Main Authors: Deng, Qin, Chen, Wenyuan, Deng, Bili, Chen, Weishi, Chen, Lei, Fan, Gengqi, Wu, Jinglan, Gao, Yuan, Chen, Xiaolan
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01.12.2024
• Subjects: Andrographis paniculata; Mechanism; Molecular docking; Network pharmacological analysis; Solar dermatitis; Kyoto encyclopedia of genes and genomes; Prostaglandin G/H synthase 2; cellular components; Network pharmacological analysis; AKT serine/threonine kinase 1; epidermal growth factor receptor; phosphatidylinositol-3-kinase; Solar dermatitis; Molecular docking; Mechanism; Interleukin-6; Matrix metalloproteinase-9; gene ontology; search tool for the retrieval of interacting genes/proteins; Tumor necrosis factor; traditional Chinese medicine systems pharmacology database; Signal transducer and activator of transcription 3; online mendelian inheritance in man; protein-protein interaction; Andrographis paniculata; wogonin; biological processes; molecular functions
• ISSN: 0944-7113; 1618-095X
• DOI: 10.1016/j.phymed.2024.156025

Solar dermatitis (SD) is an acute, damaging inflammation of the skin caused by UV exposure, especially UVB. Therefore, the discovery of novel anti-SD therapeutic agents is crucial. Andrographis paniculata (AP) is a medicinal plant with a wide range of pharmacological effects. Increased evidence shows that AP has potential therapeutic effects on SD. However, the therapeutic mechanisms of AP against SD have not yet been completely elucidated, which is an unexplored field. This study employed network pharmacology, molecular docking and experimental verification to ascertain the active constituents, possible targets, and biological pathways associated with AP in the treatment of SD. AP-related active ingredients and their potential targets were screened from TCMSP and Swiss Target Prediction database, respectively. Potential therapeutic targets of SD were collected using the GeneCards, DrugBank and OMIM databases. Then, we established protein-protein interaction (PPI), compound-target-disease (D-C-T-D) through Cytoscape to identify the major components, core targets of AP against SD. Next, the GO and KEGG pathway was identified by the David database of AP in the treatment of SD. Molecular docking techniques were used to estimate the binding force between the components and the hub genes. In this paper, we used UVB-irradiated HaCaT keratinocytes as an in vitro model and established the dorsal skin of UVB-irradiated ICR mice as an in vivo model to explore the mechanism for further verification. There were 24 active components and 63 related target genes in AP against SD. PPI analysis showed that AKT-1, TNF-α, IL6, MMP9, EGFR, and PTGS2 shared the highest centrality among all target genes. KEGG pathway analysis revealed that the PI3K-Akt signaling pathway may be central in the anti-SD system. The molecular docking results showed that the main active components of AP have strong binding affinity with hub genes. In vitro results showed that WG had a protective effect on UVB-intervened HaCat cells. Western blot analysis showed that WG intervention achieved anti-inflammation by reducing the phosphorylated expression of AKT, PI3K proteins in the PI3K-AKT signaling pathway and downregulating the expression of TNF-α, IL-6, EGFR. Furthermore, Histological analysis confirmed that administration of WG to ICR mice significantly ameliorated UVB-induced skin roughness, epidermal thickening, disturbed collagen fiber alignment and wrinkles. Meanwhile, immunohistochemistry showed that administration of WG to ICR mice significantly reduced UVB-induced expression of MMP9, MPO, F4/80 in the skin. These results provide new insights into the contribution of WG to the development of clinical treatment modalities for UVB-induced SD. The crucial element in the fight against SD is WG, with the primary route being PI3K/Akt. The main components and hub genes had robust binding abilities. In vitro and vivo experiments showed that WG could inhibit the expression level of the hub genes by inhibiting the PI3K/Akt pathway. In summary, the information presented in this study indicates that WG might be utilised as a treatment for UVB-induced SD. [Display omitted]